Steven M. Schmid

647 total citations
14 papers, 389 citations indexed

About

Steven M. Schmid is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Steven M. Schmid has authored 14 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Steven M. Schmid's work include Microtubule and mitosis dynamics (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (3 papers). Steven M. Schmid is often cited by papers focused on Microtubule and mitosis dynamics (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (3 papers). Steven M. Schmid collaborates with scholars based in United States, France and United Kingdom. Steven M. Schmid's co-authors include William R. Waud, Kenneth B. Cummings, Ernest C. Borden, John A. Montgomery, Stephanie Roth, John A. Secrist, Joan H. Schiller, Cécile Rouleau, Beverly A. Teicher and James K. V. Willson and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Clinical Cancer Research.

In The Last Decade

Steven M. Schmid

14 papers receiving 366 citations

Peers

Steven M. Schmid

ONCOL

RNMI

IMMUN

Luisa Vicari Italy

Koh Amano Japan

Toshinori Kanamori Japan

Sachiko Tai Japan

Jeremy Griggs United Kingdom

Marina Ripamonti Italy

Paul J. Kleindl United States

C. P. Eng Canada

Indranil Basu United States

Lisa Polin United States

Luisa Vicari Italy

Steven M. Schmid

285 ×1.5

141 ×1.1

ONCOL

57 ×0.9

17 ×0.3

RNMI

49 ×1.1

IMMUN

Citations per year, relative to Steven M. Schmid Steven M. Schmid (= 1×) peers Luisa Vicari

Countries citing papers authored by Steven M. Schmid

Since Specialization

Citations

This map shows the geographic impact of Steven M. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Schmid more than expected).

Fields of papers citing papers by Steven M. Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Schmid. The network helps show where Steven M. Schmid may publish in the future.

Co-authorship network of co-authors of Steven M. Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Schmid. A scholar is included among the top collaborators of Steven M. Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Schmid. Steven M. Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rouleau, Cécile, Diego A. Gianolio, Robert Smale, et al.. (2015). Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies. Molecular Cancer Therapeutics. 14(9). 2081–2089. 34 indexed citations

Gianolio, Diego A., Cécile Rouleau, William E. Bauta, et al.. (2012). Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates. Cancer Chemotherapy and Pharmacology. 70(3). 439–449. 28 indexed citations

Kurtzberg, Leslie, Stephanie Roth, Min Yao, et al.. (2011). Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment. Clinical Cancer Research. 17(9). 2777–2787. 40 indexed citations

Kurtzberg, Leslie, Stephanie Roth, Rebecca G. Bagley, et al.. (2009). Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents. Cancer Chemotherapy and Pharmacology. 64(5). 1029–1038. 4 indexed citations

Kurtzberg, Leslie, Traci E. Battle, Cécile Rouleau, et al.. (2008). Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Molecular Cancer Therapeutics. 7(10). 3212–3222. 30 indexed citations

Okouneva, Tatiana, Tapas Manna, Herbert P. Miller, et al.. (2007). Mechanism of Action of the Microtubule-Targeted Antimitotic Depsipeptide Tasidotin (Formerly ILX651) and Its Major Metabolite Tasidotin C-Carboxylate. Cancer Research. 67(8). 3767–3776. 37 indexed citations

Samuel, Shanti K., et al.. (2003). The mechanism of action of docetaxel (Taxotere®) in xenograft models is not limited to bcl-2 phosphorylation. Investigational New Drugs. 21(3). 259–268. 46 indexed citations

Reynolds, Robert C., et al.. (2000). Synthesis and Evaluation of Several New (2-Chloroethyl)nitrosocarbamates as Potential Anticancer Agents. Journal of Medicinal Chemistry. 43(8). 1484–1488. 19 indexed citations

Waud, William R., Steven M. Schmid, John A. Montgomery, & John A. Secrist. (2000). Preclinical Antitumor Activity of 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine (C1-F-Ara-A). Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 447–460. 40 indexed citations

10.

Struck, Robert F., Steven M. Schmid, & William R. Waud. (1994). Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide. Cancer Chemotherapy and Pharmacology. 34(3). 191–196. 12 indexed citations

11.

McMahon, James, Steven M. Schmid, O. S. Weislow, et al.. (1990). Feasibility of Cellular Microencapsulation Technology for Evaluation of Anti-Human Immunodeficiency Virus Drugs In Vivo. JNCI Journal of the National Cancer Institute. 82(22). 1761–1765. 10 indexed citations

12.

Ruzicka, Frank J., et al.. (1987). Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.. PubMed. 47(17). 4582–9. 6 indexed citations

13.

Yang, An Hang, Terry D. Oberley, Larry W. Oberley, Steven M. Schmid, & Kenneth B. Cummings. (1987). In vitro modulation of antioxidant enzymes in normal and malignant renal epithelium. In Vitro Cellular & Developmental Biology - Plant. 23(8). 546–558. 24 indexed citations

14.

Schiller, Joan H., et al.. (1986). Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.. PubMed. 46(2). 483–8. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact